Acutus Medical, Inc.
NASDAQ:AFIB
0.142 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 26.2 | 25.584 | 24.071 | 25.234 | 9.452 | 9.625 |
| Short Term Investments
| 3.233 | 44.863 | 76.702 | 105.839 | 62.351 | 8.12 |
| Cash and Short Term Investments
| 29.433 | 70.447 | 100.773 | 131.073 | 71.803 | 17.745 |
| Net Receivables
| 11.353 | 21.085 | 3.633 | 2.16 | 0.263 | 0.164 |
| Inventory
| 4.278 | 13.327 | 16.408 | 12.958 | 8.424 | 3.003 |
| Other Current Assets
| 1.188 | 7.244 | 5.476 | 5.197 | 1.966 | 1.027 |
| Total Current Assets
| 46.252 | 117.867 | 126.29 | 151.388 | 82.456 | 21.939 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 4.014 | 13.093 | 18.191 | 14.025 | 6.768 | 3.922 |
| Goodwill
| 0 | 0 | 12.026 | 12.026 | 12.026 | 0 |
| Intangible Assets
| 0 | 1.583 | 5.013 | 5.653 | 4.11 | 0 |
| Goodwill and Intangible Assets
| 0 | 1.583 | 17.039 | 17.679 | 16.136 | 0 |
| Long Term Investments
| 0 | 0.5 | 7.12 | 8.726 | 0 | 0 |
| Tax Assets
| 0 | -0.5 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 3.694 | 0.897 | 1.152 | 0.717 | 0.095 | 0.087 |
| Total Non-Current Assets
| 7.708 | 15.573 | 43.502 | 41.147 | 22.999 | 4.009 |
| Total Assets
| 53.96 | 133.44 | 169.792 | 192.535 | 105.455 | 25.948 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 2.761 | 4.721 | 7.519 | 8.266 | 3.882 | 1.597 |
| Short Term Debt
| 2.582 | 0.319 | 0.395 | 0.933 | 0.833 | 11.274 |
| Tax Payables
| 0 | 0.639 | 0.071 | 0.169 | 0 | 0 |
| Deferred Revenue
| 0 | 0.326 | 0.401 | 0.301 | 0.311 | 0.318 |
| Other Current Liabilities
| 13.599 | 14.506 | 10.195 | 12.407 | 26.884 | 11.673 |
| Total Current Liabilities
| 18.942 | 19.872 | 18.51 | 21.907 | 31.91 | 24.862 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 32.654 | 38.537 | 45.006 | 40.145 | 40.298 | 14.591 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 3.243 | 0.012 | 0.55 | 3.9 | 259.058 | 118.319 |
| Total Non-Current Liabilities
| 35.897 | 38.549 | 45.556 | 44.045 | 299.356 | 132.91 |
| Total Liabilities
| 54.839 | 58.421 | 64.066 | 65.952 | 331.266 | 157.772 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 0 | 192.535 | 0 | 0 |
| Common Stock
| 0.029 | 0.029 | 0.028 | 0.028 | 0.001 | 0.001 |
| Retained Earnings
| -599.977 | -518.314 | -478.698 | -361.015 | -259.034 | -161.995 |
| Accumulated Other Comprehensive Income/Loss
| -0.866 | -0.869 | -0.217 | 0.28 | -0.03 | 0.02 |
| Other Total Stockholders Equity
| 599.935 | 594.173 | 584.613 | 294.755 | 33.252 | 30.15 |
| Total Shareholders Equity
| -0.879 | 75.019 | 105.726 | 126.583 | -225.811 | -131.824 |
| Total Equity
| -0.879 | 75.019 | 105.726 | 126.583 | -225.811 | -131.824 |
| Total Liabilities & Shareholders Equity
| 53.96 | 133.44 | 169.792 | 192.535 | 105.455 | 25.948 |